News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
711,720 Results
Type
Article (40410)
Company Profile (261)
Press Release (671038)
Multimedia
Podcasts (70)
Webinars (16)
Section
Business (204468)
Career Advice (2016)
Deals (35476)
Drug Delivery (99)
Drug Development (81233)
Employer Resources (173)
FDA (16309)
Job Trends (14914)
News (345898)
Policy (32682)
Tag
Academia (2558)
Accelerated approval (15)
Adcomms (24)
Allergies (112)
Alliances (49572)
ALS (132)
Alzheimer's disease (1549)
Antibody-drug conjugate (ADC) (191)
Approvals (16388)
Artificial intelligence (377)
Autoimmune disease (59)
Automation (25)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (144)
Biotechnology (175)
Bladder cancer (117)
Brain cancer (44)
Breast cancer (451)
Cancer (3563)
Cardiovascular disease (292)
Career advice (1693)
Career pathing (33)
CAR-T (217)
CDC (42)
Cell therapy (585)
Cervical cancer (30)
Clinical research (67818)
Collaboration (1251)
Company closure (4)
Compensation (901)
Complete response letters (42)
COVID-19 (2669)
CRISPR (70)
C-suite (531)
Cystic fibrosis (123)
Data (4174)
Decentralized trials (2)
Denatured (22)
Depression (90)
Diabetes (410)
Diagnostics (6523)
Digital health (32)
Diversity (10)
Diversity, equity & inclusion (45)
Drug discovery (174)
Drug pricing (152)
Drug shortages (28)
Duchenne muscular dystrophy (189)
Earnings (88641)
Editorial (45)
Employer branding (21)
Employer resources (150)
Events (115033)
Executive appointments (914)
FDA (18621)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (13)
Funding (1141)
Gene editing (155)
Generative AI (28)
Gene therapy (468)
GLP-1 (853)
Government (4593)
Grass and pollen (5)
Guidances (334)
Healthcare (18854)
HIV (42)
Huntington's disease (34)
IgA nephropathy (50)
Immunology and inflammation (197)
Immuno-oncology (15)
Indications (51)
Infectious disease (2875)
Inflammatory bowel disease (167)
Inflation Reduction Act (12)
Influenza (83)
Intellectual property (177)
Interviews (314)
IPO (16607)
IRA (48)
Job creations (3639)
Job search strategy (1426)
Kidney cancer (13)
Labor market (68)
Layoffs (530)
Leadership (24)
Legal (7937)
Liver cancer (84)
Longevity (11)
Lung cancer (509)
Lymphoma (252)
Machine learning (27)
Management (59)
Manufacturing (560)
MASH (126)
Medical device (13590)
Medtech (13611)
Mergers & acquisitions (19717)
Metabolic disorders (1005)
Multiple sclerosis (130)
NASH (16)
Neurodegenerative disease (192)
Neuropsychiatric disorders (47)
Neuroscience (2472)
NextGen: Class of 2025 (6516)
Non-profit (4492)
Now hiring (56)
Obesity (474)
Opinion (235)
Ovarian cancer (123)
Pain (143)
Pancreatic cancer (161)
Parkinson's disease (221)
Partnered (27)
Patents (389)
Patient recruitment (290)
Peanut (52)
People (58156)
Pharmaceutical (63)
Pharmacy benefit managers (23)
Phase I (21110)
Phase II (29865)
Phase III (22214)
Pipeline (2586)
Policy (242)
Postmarket research (2564)
Preclinical (8991)
Press Release (64)
Prostate cancer (182)
Psychedelics (41)
Radiopharmaceuticals (256)
Rare diseases (572)
Real estate (5935)
Recruiting (68)
Regulatory (23353)
Reports (51)
Research institute (2347)
Resumes & cover letters (351)
Rett syndrome (14)
RNA editing (11)
RSV (61)
Schizophrenia (120)
Series A (186)
Series B (143)
Service/supplier (11)
Sickle cell disease (72)
Special edition (20)
Spinal muscular atrophy (149)
Sponsored (34)
Startups (3598)
State (2)
Stomach cancer (14)
Supply chain (91)
Tariffs (79)
The Weekly (46)
Vaccines (884)
Venture capital (62)
Weight loss (306)
Women's health (53)
Worklife (17)
Date
Today (133)
Last 7 days (498)
Last 30 days (2267)
Last 365 days (30600)
2025 (23612)
2024 (35218)
2023 (40076)
2022 (51180)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32108)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (725)
Alabama (71)
Alaska (7)
Arizona (265)
Arkansas (13)
Asia (38572)
Australia (6300)
California (8941)
Canada (2762)
China (809)
Colorado (379)
Connecticut (384)
Delaware (244)
Europe (83083)
Florida (1333)
Georgia (293)
Hawaii (2)
Idaho (60)
Illinois (698)
India (43)
Indiana (426)
Iowa (17)
Japan (300)
Kansas (117)
Kentucky (33)
Louisiana (16)
Maine (67)
Maryland (1181)
Massachusetts (6547)
Michigan (276)
Minnesota (520)
Mississippi (4)
Missouri (106)
Montana (29)
Nebraska (25)
Nevada (101)
New Hampshire (69)
New Jersey (2452)
New Mexico (28)
New York (2435)
North Carolina (1233)
North Dakota (8)
Northern California (4107)
Ohio (274)
Oklahoma (20)
Oregon (36)
Pennsylvania (1891)
Puerto Rico (18)
Rhode Island (43)
South America (1099)
South Carolina (46)
South Dakota (1)
Southern California (3445)
Tennessee (145)
Texas (1380)
United States (32514)
Utah (265)
Virginia (216)
Washington D.C. (76)
Washington State (749)
West Virginia (4)
Wisconsin (76)
Wyoming (1)
711,720 Results for "seaspine inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Orthofix Medical Inc. Announces Preliminary SeaSpine and Orthofix 2022 Fourth Quarter and Full-Year Net Sales Results
The merger of equals between Orthofix Medical Inc. (“Orthofix”) and SeaSpine Holdings Corporation (“SeaSpine”) became effective as of January 5, 2023.
January 9, 2023
·
13 min read
Deals
Orthofix Medical Reports Orthofix and SeaSpine Fourth Quarter and Full-Year 2022 Results
The merger of Orthofix Medical Inc. (“Orthofix”) and SeaSpine Holdings Corporation (“SeaSpine”) became effective as of January 5, 2023.
March 6, 2023
·
25 min read
Press Releases
Apollomics, Inc. Company Operational Continuity Update
October 14, 2025
·
6 min read
Press Releases
Co-Diagnostics, Inc. to Attend 2025 Maxim Growth Summit
October 14, 2025
·
2 min read
Press Releases
FOXO TECHNOLOGIES INC. ANNOUNCES ACQUISITION AGREEMENT TO ACQUIRE VECTOR BIOSOURCE INC.
September 11, 2025
·
4 min read
Press Releases
Apogee Therapeutics, Inc. Announces Proposed Underwritten Public Offering
October 9, 2025
·
5 min read
Deals
Orthofix and SeaSpine Announce Completion of Merger of Equals to Create a Leading Global Spine and Orthopedics Company
Orthofix Medical Inc. and SeaSpine Holdings Corporation announced the successful completion of their previously announced merger of equals following the approval of each company’s stockholders at respective special meetings of stockholders.
January 4, 2023
·
8 min read
Press Releases
KBI Biopharma, Inc. Announces Collaboration with Infinimmune Inc. to Support Antibody Manufacturing
September 9, 2025
·
3 min read
Press Releases
Revagenix, Inc. Announces Changes to Its Board of Directors
September 30, 2025
·
2 min read
Press Releases
NanoViricides, Inc. Has Filed its Annual Report
October 1, 2025
·
15 min read
1 of 71,172
Next
